Hormone Excretion in Precocious Puberty

نویسندگان

  • R. D. ' BULBROOK
  • F. C. GREENWOOD
  • A. H. SNAITH
چکیده

At puberty in girls the sex hormones are secreted in increasing quantities and the clinical signs of puberty follow. In precocious puberty it is generally accepted that the excretion of these hormones will reach adolescent or adult levels but will not be abnormally high as it may be in tumour or hyperplasia of the gonad or the adrenal cortex. Published reports vary depending on the laboratory investigations carried out, and also from case to case (Fischer, 1940; Novak, 1944; Hain, 1947; Seckel, Scott and Benditt, 1949; Lloyd, Lobotsky and Morley, 1950; Lowrey and Brown, 1951; Mossberg, 1951; Paschkis, 1952; Lloyd, 1955). In general, the 17-ketosteroids tend to be a little higher than normal for the chronological age but they rarely reach more than the lower limits of adult levels and may be quite normal. Gonadotrophin determinations are usually positive, but were negative in the cases described by Gross (1940) and by Bronstein, Luhan and Mavrelis (1942). Oestrogen excretion has been measured by biological methods. The results are difficult to evaluate but on the whole oestrogen excretion tends to be low. The chemical method recently developed by Brown (1 955a) has made possible the separate estimation of oestrone, oestradiol-17,B and oestriol in human urine. This study was therefore undertaken to assess the clinical value of simultaneous estimations of urinary oestrogens, 1 7-ketosteroids and gonadotrophins in 11 cases of early or precocious puberty. Vaginal smears were also examined. Hormone estimations were carried out on a cont'rol series of 15 normal girls in the age range 3 to 10 years.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Is precocious puberty linked to hypothalamic expression of arginine-phenylalanine-amide-related peptide?

The up-regulator regulation and down-regulator regulation of gonadotropin-releasing hormone (GnRH) in central precocious puberty is not yet known. However, recent advances in neuroendocrinology have shown the controlling role of arginine-phenylalanine (RF)-amide-related peptides (RFRPs) on GnRH secretion in different phenomenon of reproduction such as estrus cycle and pregnancy, but the exact r...

متن کامل

TREATMENT OF PRECOCIOUS PUBERTY BY A LONG-ACTING GONADOTROPIN-RELEASING HORMONE ANALOGUE IN CHILDREN

The GnRH analogue has been shown to be effective in the treatment of precocious puberty when given as a daily subcutaneous injection. We studied the effectiveness of a long-acting GnRH analogue, Triptoreline, for the treatment of central precocity, by suppressing gonadotropin and estradiol secretion in three children with true precocious puberty. One month after single dose intramuscular i...

متن کامل

Output of luteinizing hormone in the urine of normal children and those with advanced sexual development.

Buckler, J. M. H., and Clayton, B. E. (1970). Archives of Disease in Childhood, 45, 478. Output of luteinzing hormone in the urine of normal children and those with advanced sexual development. Estimations by radioimmunoassay of the 24-hour excretion of LH in normal children (152 boys and 104 girls) have shown high values in the first six months of life in boys, and possibly girls, and then low...

متن کامل

Clinical and laboratory findings in the differential diagnosis of central precocious puberty and premature thelarche.

AIM In this study, it was aimed to evaluate the clinical, antropometric and laboratory findings of female patients diagnosed with central precocious puberty and to determine the laboratory value with the best diagnostic accuracy in the diagnosis of central precocious puberty. MATERIALS AND METHOD Female patients whose breast development began before the age of 8 years were included in the stu...

متن کامل

Combined use of growth hormone and gonadotropin-releasing hormone analogues in precocious puberty: theoretic and practical considerations.

The rationale underlying the use of gonadotropin-releasing hormone analogues (GnRHa) to treat patients with central precocious puberty is reviewed. GnRHa are now considered the treatment of choice for patients with central precocious puberty, but the adult heights that these patients attain often fall short of what would be expected according to their genetic potential. This has led to investig...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2007